# KZR (Kezar Life Sciences, Inc.) - SEC EDGAR Financial Statements

> Kezar Life Sciences, Inc. reported $0 in revenue and a net loss of $45.23M for the fiscal year ended December 31, 2025.

- Canonical: https://convexityos.com/fundamentals/KZR
- Markdown: https://convexityos.com/fundamentals/KZR.md
- SEC CIK: 0001645666
- Reporting currency: USD
- Latest filing period: March 31, 2026
- Last synced: Nov 20, 2026, 05:52 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001645666&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | $0 | Dec 31, 2025 |
| Operating Income | FY 2025 | -$48.84M | Operating profit |
| Net Income | FY 2025 | -$45.23M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$6.16 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$42.03M | Operating CF less CapEx |
| Cash & ST Investments | Mar 31, 2026 | $66.23M | Total debt: $1.35M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $0 | $0 | $7.00M | $0 | $0 | -- | -- | -- | -- | -- |
| Research & Development | $33.76M | $65.74M | $85.70M | $51.01M | $38.94M | $30.98M | $27.36M | $18.14M | $6.47M | $7.37M |
| Total Operating Expenses | $59.11M | $90.61M | $118.4M | $71.16M | $54.66M | $42.95M | $37.34M | $24.73M | $8.75M | $8.99M |
| **Operating Income** | -$59.11M | -$90.61M | -$111.4M | -$71.16M | -$54.66M | -$42.95M | -$37.34M | -$24.73M | -$8.75M | -$8.99M |
| **EBITDA** | -$58.21M | -$89.56M | -$110.4M | -$70.14M | -$53.15M | -$41.41M | -$36.04M | -$24.04M | -$8.57M | -$8.84M |
| Interest Income | $4.44M | $8.46M | $11.10M | $4.11M | -- | -- | -- | -- | -- | -- |
| Interest Expense | -- | $1.59M | $1.55M | $1.19M | $159K | $0 | -- | -- | -- | -- |
| Income Before Tax | -$56.03M | -$83.74M | -$101.9M | -- | -- | -- | -- | -- | -- | -- |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$56.03M | -$83.74M | -$101.9M | -$68.24M | -$54.63M | -$41.74M | -$35.09M | -$23.17M | -$8.52M | -$8.99M |
| Basic EPS | -$7.66 | -$11.49 | -$14.04 | -$10.13 | -$10.40 | -$9.50 | -$18.40 | -$22.60 | -$142.10 | -$265.60 |
| **Diluted EPS** | -$7.66 | -$11.49 | -$14.04 | -$10.13 | -$10.40 | -$9.50 | -$18.40 | -$22.60 | -$142.10 | -$265.60 |
| Basic Shares Outstanding | 7.3M | 7.3M | 7.3M | 6.7M | 5.3M | 4.4M | 1.9M | 1.0M | 59.9K | 33.8K |
| Diluted Shares Outstanding | 7.3M | 7.3M | 7.3M | 6.7M | 5.3M | 4.4M | 1.9M | 1.0M | 59.9K | 33.8K |

### Income Statement (Quarterly)

| Line Item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | -- | -- | -- | -- | -- | $0 | -- |
| Research & Development | $1.54M | $5.08M | $6.91M | $9.58M | $12.18M | $16.03M | $16.24M | $16.30M |
| Total Operating Expenses | $7.37M | $15.16M | $11.71M | $14.60M | $17.63M | $21.56M | $21.95M | $23.38M |
| **Operating Income** | -$7.37M | -$15.16M | -$11.71M | -$14.60M | -$17.63M | -$21.56M | -$21.95M | -$23.38M |
| **EBITDA** | -$7.32M | -$14.99M | -$11.49M | -$14.36M | -$17.38M | -$21.30M | -$21.69M | -$23.12M |
| Interest Income | $609K | $801K | $1.03M | $1.20M | $1.42M | $1.73M | $2.04M | $2.24M |
| Interest Expense | $0 | -- | -- | $302K | $347K | -- | $403K | $401K |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$5.76M | -$14.55M | -$11.23M | -$13.70M | -$16.56M | -$20.22M | -$20.31M | -$21.55M |
| Basic EPS | -$0.78 | -- | -$1.53 | -$1.87 | -$2.27 | -- | -$2.78 | -$2.96 |
| **Diluted EPS** | -$0.78 | -- | -$1.53 | -$1.87 | -$2.27 | -- | -$2.78 | -$2.96 |
| Basic Shares Outstanding | 7.3M | -- | 7.3M | 7.3M | 7.3M | -- | 7.3M | 7.3M |
| Diluted Shares Outstanding | 7.3M | -- | 7.3M | 7.3M | 7.3M | -- | 7.3M | 7.3M |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $71.88M | $41.75M | $35.49M | $40.46M | $62.88M | $21.23M | $14.95M | $24.18M | $51.03M |
| Short-Term Investments | $0 | $90.50M | $165.9M | $236.1M | $145.5M | $119.2M | $63.26M | $83.25M | -- |
| **Cash & Short-Term Investments** | $71.88M | $132.2M | $201.4M | $276.6M | $208.4M | $140.4M | $78.21M | $107.4M | $51.03M |
| Accounts Receivable, Net | -- | -- | -- | $0 | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | $920K | $729K | $1.63M | $1.05M | $489K | $508K |
| **Total Current Assets** | $75.73M | $137.5M | $206.9M | $285.7M | $211.7M | $144.8M | $81.13M | $109.8M | $52.33M |
| Property, Plant & Equipment, Net | $166K | $2.89M | $3.91M | $3.43M | $3.28M | $3.44M | $4.28M | $4.59M | $1.54M |
| Other Non-Current Assets | $0 | $2.42M | $5.59M | $674K | $282K | $282K | $282K | $282K | $343K |
| **Total Non-Current Assets** | $915K | $7.19M | $14.29M | $13.85M | $6.28M | $7.03M | $8.38M | $4.88M | $1.90M |
| **Total Assets** | $76.65M | $144.7M | $221.2M | $299.6M | $217.9M | $151.8M | $89.51M | $114.7M | $54.22M |
| Accounts Payable | $507K | $3.65M | $8.25M | $2.48M | $2.03M | $2.36M | $823K | $193K | $547K |
| Short-Term Debt | $0 | $5.22M | $0 | -- | -- | -- | -- | -- | -- |
| Other Current Liabilities | -- | -- | -- | -- | -- | $21K | $62K | $112K | $26K |
| **Total Current Liabilities** | $6.57M | $20.33M | $17.74M | $11.00M | $8.21M | $6.44M | $6.00M | $3.34M | $1.48M |
| Long-Term Debt | $0 | $5.11M | $10.07M | $9.83M | $9.62M | -- | -- | -- | -- |
| **Total Non-Current Liabilities** | $0 | $7.44M | $15.92M | $18.70M | $12.85M | $4.42M | $5.46M | $2.55M | $494K |
| **Total Liabilities** | $6.57M | $27.77M | $33.66M | $29.70M | $21.06M | $10.86M | $11.47M | $5.88M | $1.98M |
| **Total Debt (incl. Leases)** | $2.33M | $16.18M | $18.93M | $21.26M | $14.04M | $5.46M | $6.36M | -- | -- |
| Common Stock | $7.0K | $7.0K | $7.0K | $68K | $56K | $46K | $19K | $19K | $1.0K |
| Retained Earnings | -$490.5M | -$434.5M | -$350.8M | -$248.9M | -$180.7M | -$126.0M | -$84.28M | -$49.20M | -$26.03M |
| Accumulated Other Comp. Income | $0 | -$162K | -$130K | -$923K | -$291K | -$137K | -$196K | -$203K | -$111K |
| **Total Stockholders' Equity** | $70.07M | $116.9M | $187.6M | $269.9M | $196.9M | $141.0M | $78.05M | $108.8M | -$25.69M |
| Total Equity | $70.07M | $116.9M | $187.6M | $269.9M | $196.9M | $141.0M | $78.05M | $108.8M | -$25.69M |

### Balance Sheet (Quarterly)

| Line Item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $66.23M | $71.88M | $38.94M | $34.37M | $37.00M | $41.75M | $34.86M | $28.28M |
| Short-Term Investments | -- | $0 | $51.28M | $66.48M | $77.36M | $90.50M | $113.5M | $135.9M |
| **Cash & Short-Term Investments** | $66.23M | $71.88M | $90.22M | $100.8M | $114.4M | $132.2M | $148.4M | $164.2M |
| **Total Current Assets** | $67.56M | $75.73M | $94.50M | $104.7M | $120.3M | $137.5M | $156.4M | $167.6M |
| Property, Plant & Equipment, Net | $0 | $166K | $2.17M | $2.41M | $2.65M | $2.89M | $3.15M | $3.39M |
| Other Non-Current Assets | -- | $0 | $0 | $674K | $674K | $2.42M | $2.42M | $6.52M |
| **Total Non-Current Assets** | $436K | $915K | $3.23M | $4.42M | $4.94M | $7.19M | $7.71M | $12.30M |
| **Total Assets** | $68.00M | $76.65M | $97.73M | $109.1M | $125.3M | $144.7M | $164.1M | $179.9M |
| Accounts Payable | $273K | $507K | $911K | $1.16M | $1.97M | $3.65M | $3.46M | $2.26M |
| Short-Term Debt | -- | $0 | $5.28M | $5.29M | $5.22M | $5.22M | $3.91M | $2.61M |
| **Total Current Liabilities** | $2.76M | $6.57M | $13.38M | $14.37M | $16.96M | $20.33M | $20.43M | $17.50M |
| Long-Term Debt | -- | $0 | $1.37M | $2.63M | $3.87M | $5.11M | $6.35M | $7.59M |
| **Total Non-Current Liabilities** | $0 | $0 | $1.37M | $2.97M | $5.23M | $7.44M | $9.61M | $11.74M |
| **Total Liabilities** | $2.76M | $6.57M | $14.75M | $17.34M | $22.19M | $27.77M | $30.04M | $29.24M |
| **Total Debt (incl. Leases)** | $1.35M | $2.33M | $9.91M | $12.07M | $14.11M | $16.18M | $16.91M | $17.61M |
| Common Stock | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $73K |
| Retained Earnings | -$496.3M | -$490.5M | -$476.0M | -$464.8M | -$451.1M | -$434.5M | -$414.3M | -$394.0M |
| Accumulated Other Comp. Income | $0 | $0 | $14K | -$267K | -$232K | -$162K | $107K | -$385K |
| **Total Stockholders' Equity** | $65.24M | $70.07M | $82.98M | $91.79M | $103.1M | $116.9M | $134.0M | $150.7M |
| Total Equity | $65.24M | $70.07M | $82.98M | $91.79M | $103.1M | $116.9M | $134.0M | $150.7M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$56.03M | -$83.74M | -$101.9M | -$68.24M | -$54.63M | -$41.74M | -$35.09M | -$23.17M | -$8.52M | -$8.99M |
| Depreciation & Amortization | $897K | $1.04M | $1.07M | $1.02M | $1.51M | $1.54M | $1.30M | $690K | $175K | $154K |
| Stock-Based Compensation | $8.96M | $13.01M | $18.14M | $14.01M | $7.60M | $4.94M | $4.01M | $1.99M | $203K | $128K |
| **Operating Cash Flow** | -$51.78M | -$74.21M | -$81.64M | -$58.85M | -$42.44M | -$36.95M | -$29.88M | -$20.79M | -$8.11M | -$9.76M |
| Capital Expenditure | -$8.0K | -$29K | -$1.81M | -$1.58M | -$316K | -$194K | -$607K | -$1.12M | -$389K | -$132K |
| **Free Cash Flow** | -$51.78M | -$74.24M | -$83.45M | -$60.42M | -$42.75M | -$37.14M | -$30.48M | -$21.91M | -$8.50M | -$9.89M |
| Purchases of Investments | -$42.63M | -$91.34M | -$180.4M | -$332.2M | -$156.4M | -$225.7M | -$102.3M | -$119.2M | -- | -- |
| **Investing Cash Flow** | $92.46M | $80.43M | $76.05M | -$91.39M | -$28.44M | -$56.50M | $20.42M | -$83.90M | -$389K | -$132K |
| Common Stock Issued | -- | -- | -- | -- | -- | -- | -- | $77.69M | -- | -- |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -- | -- |
| **Financing Cash Flow** | -$10.59M | $103K | $638K | $127.9M | $112.6M | $99.64M | $272K | $77.91M | $49.76M | $36K |
| **Net Change in Cash** | $30.13M | $6.26M | -$4.96M | -$22.43M | $41.65M | $6.28M | -$9.23M | -$26.86M | $41.29M | -$10.01M |

### Cash Flow Statement (Quarterly)

| Line Item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$5.76M | -$14.55M | -$11.23M | -$13.70M | -$16.56M | -$20.22M | -$20.31M | -$21.55M |
| Depreciation & Amortization | $47K | $176K | $227K | $243K | $251K | $259K | $260K | $261K |
| Stock-Based Compensation | $653K | $1.63M | $2.14M | $2.42M | $2.78M | $3.31M | $3.19M | $3.08M |
| **Operating Cash Flow** | -$7.45M | -$11.96M | -$9.83M | -$12.79M | -$17.19M | -$16.82M | -$17.49M | -$17.03M |
| Capital Expenditure | $0 | $0 | $0 | $0 | -$8.0K | -$11K | -$18K | $0 |
| **Free Cash Flow** | -$7.45M | -$11.96M | -$9.83M | -$12.79M | -$17.20M | -$16.84M | -$17.51M | -$17.03M |
| Purchases of Investments | -- | $0 | -$14.30M | -$28.33M | $0 | -$19.23M | -$19.98M | -$34.78M |
| **Investing Cash Flow** | $1.53M | $51.61M | $15.71M | $11.40M | $13.74M | $23.74M | $24.06M | $12.22M |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Financing Cash Flow** | $267K | -$6.71M | -$1.30M | -$1.27M | -$1.30M | $47K | $0 | $56K |
| **Net Change in Cash** | -$5.65M | $32.94M | $4.57M | -$2.63M | -$4.75M | $6.89M | $6.58M | -$4.76M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -- | -- | -1591.8% | -- | -- | -- | -- | -- | -- | -- |
| **Net Profit Margin** | -- | -- | -1455.3% | -- | -- | -- | -- | -- | -- | -- |
| Return on Equity (ROE) | -80.0% | -71.6% | -54.3% | -25.3% | -27.7% | -29.6% | -45.0% | -21.3% | -- | -- |
| Return on Assets (ROA) | -73.1% | -57.9% | -46.0% | -22.8% | -25.1% | -27.5% | -39.2% | -20.2% | -15.7% | -- |
| Current Ratio | 11.52x | 6.76x | 11.66x | 25.98x | 25.77x | 22.48x | 13.52x | 32.91x | 35.26x | -- |
| Quick Ratio | 10.93x | 6.51x | 11.35x | 25.15x | 25.37x | 21.80x | 13.03x | 32.19x | 34.39x | -- |
| Debt to Equity | 0.03x | 0.14x | 0.10x | 0.08x | 0.07x | 0.04x | 0.08x | -- | -- | -- |
| **Revenue Growth (YoY)** | -- | -100.0% | -- | -- | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -69.3% | -80.0% | -74.4% | -77.1% | -76.3% | -71.6% | -71.4% | -65.4% |
| Return on Assets (ROA) | -66.5% | -73.1% | -63.1% | -64.9% | -62.8% | -57.9% | -58.4% | -54.8% |
| Current Ratio | 24.46x | 11.52x | 7.06x | 7.29x | 7.09x | 6.76x | 7.65x | 9.58x |
| Quick Ratio | 23.98x | 10.93x | 6.74x | 7.02x | 6.74x | 6.51x | 7.26x | 9.38x |
| Debt to Equity | 0.02x | 0.03x | 0.12x | 0.13x | 0.14x | 0.14x | 0.13x | 0.12x |
| **Revenue Growth (YoY)** | -- | -- | -- | -- | -- | -- | -100.0% | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
